The tariff classification of Anti-trimethyl-Histone H3 (Lys9) polyclonal antibody packed for retail sale from Canada
Reasoning
The tariff classification of Anti-trimethyl-Histone H3 (Lys9) polyclonal antibody packed for retail sale from Canada
Cite this ruling
CBP Ruling N294981 (3002150000): The tariff classification of Anti-trimethyl-Histone H3 (Lys9) polyclonal antibody packed for retail sale from Canada
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300215
The tariff classification of polyclonal rabbit antibodies from India
The tariff classification of Ogivri ™ (Trastuzumab-dkst for Injection) in dosage form, from India
The tariff classification of Brazikumab (MEDI2070) and Brazikumab (AMG 139 MEDI2070) (CAS No. 1610353-18-8) in dosage form, from the United States and imported from Ireland
The tariff classification of Fulphila™ (Pegfilgrastim-jmdb) Injection in dosage form, from India
The tariff classification of the Human Insulin ELISA (Enzyme-Linked Immunosorbent Assay) kit from the United States and imported from the United Kingdom